December 19, 2018 by Chain Drug Review
Aetna, CVS Health, CVS-Aetna deal, U.S. District Judge Richard Leon
Featured Articles, Leading Headlines

WASHINGTON—According to various published reports, a federal judge on Tuesday “softened” his previous suggestion that he would likely order CVS Health to halt its integration of Aetna. U.S. District Judge Richard Leon in recent weeks had voiced some concerns about the companies’ settlement with Justice Department antitrust enforcers that allowed the nearly $70 billion deal
December 3, 2018 by Chain Drug Review
CVS-Aetna deal, Department of Justice, U.S. District Judge Richard Leon
Leading Headlines, Retail News

WASHINGTON — According to an article in the Wall Street Journal, a federal judge has expressed concerns about the Justice Department’s decision to allow CVS Health Corp.’s nearly $70 billion acquisition of Aetna Inc.— and said he may require CVS to hold Aetna’s assets separately while he considers the settlement between the companies and the government.
November 28, 2018 by Chain Drug Review
Aetna, CVS Health, CVS Pharmacy, CVS-Aetna deal, Larry Merlo
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. – CVS Health today announced that it has completed its acquisition of Aetna establishing CVS Health as the nation’s premier health innovation company. “Today marks the start of a new day in health care and a transformative moment for our company and our industry,” declared CVS Health president and chief executive officer Larry Merlo.
November 26, 2018 by Chain Drug Review
Cuomo administration, CVS Health, CVS-Aetna deal, Department of Financial Services, Maria Vullo
Leading Headlines

WOONSOCKET, R.I. — According to published reports in Crain’s New York Business, the state Department of Financial Services has approved CVS Health’s $69 billion acquisition of insurer Aetna on Monday morning, lifting the final hurdle to the deal’s closure. Aetna said in a Securities and Exchange Commission filing the companies expect the deal to close
November 20, 2018 by Chain Drug Review
CVS Health, CVS-Aetna deal
Leading Headlines, Retail News

WOONSOCKET, R.I. — According to published reports, CVS Health says it now expects to close its $69 billion acquisition of Aetna after the Thanksgiving holiday, after saying earlier this month that it anticipated the deal would close before the holiday. CVS says it has received approval from 26 of the 28 state departments of insurance and
November 7, 2018 by Chain Drug Review
CVS, CVS-Aetna deal, Larry Merlo
Leading Headlines, Retail News

WOONSOCKET, R.I. — During yesterday’s earnings call, chief executive officer Larry Merlo reported that after the Aetna deal is finalized, CVS plans to open its first concept stores early next year. During the call Merlo outlined areas where the company will focus on to reduce medical costs for the combined company once the deal closes. Merlo
November 6, 2018 by Chain Drug Review
CVS Health, CVS-Aetna deal, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News

WOONSOCKET, R.I. — Strong gains in the pharmacy retail business helped CVS Health beat analysts’ third quarter earnings and revenue expectations. The company also announced on Tuesday that it anticipates the $69 billion Aetna deal to close before Thanksgiving. Net revenues for the three months ended September 30 increased 2.4%, or $1.1 billion, to about
December 27, 2017 by Brian McDonagh, Gregg Lipman and Chain Drug Review
Aetna, Brian McDonagh, CBX, CVS Health, CVS-Aetna deal, CVS-Aetna merger, Gregg Lipman, MinuteClinic
2018, Issue 01-01-2018, Issues, Leading Headlines, Opinion

The pending $69 billion acquisition of Aetna by CVS could yield valuable lessons for others in the health care and drugstore sectors as they seek to forge stronger ties to consumers. What interests us here is the potential for the CVS-Aetna merger to create new, meaningfully differentiated brand experiences for consumers. CVS has nearly 10,000
November 30, 2017 by CDR Blog and Chain Drug Review
Aetna, CVS Health, CVS-Aetna deal
CDR Blog

Speculation about a potential CVS Health acquisition of health insurer Aetna has been mounting over the past month, and now it may have reached a crescendo. Published reports say the companies are in advanced negotiations and that a CVS-Aetna deal could be announced as soon as next week, according to an anonymous source cited in
November 6, 2017 by Bill Schiffner
Adam Fein, Aetna, Amazon, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna deal, Humana, Larry Merlo, Mark Bertolini, MinuteClinic, OptumRx, Pembroke Consulting, UnitedHealth
2017, Issue 11-06-2017, Issues, News

WOONSOCKET, R.I. — At presstime The Wall Street Journal along with other news agencies reported that CVS Health will offer more than $200 per share, or about $66 billion, to purchase the health insurance giant Aetna Inc. Anonymous sources cited by WSJ originated the story about a potential CVS-Aetna deal. The possible transaction comes as
October 26, 2017 by CDR Blog and Chain Drug Review
Aetna, Amazon, Brian Tanquilut, CVS Health, CVS-Aetna deal, Jefferies
CDR Blog, Featured Articles, Leading Headlines

Published reports said Thursday that CVS Health is in negotiations to acquire health insurer Aetna. CVS reportedly will offer more than $200 share, or about $66 billion, to purchase the health benefits giant, according to anonymous sources cited by the Wall Street Journal, which originated the story about a potential CVS-Aetna deal. Bloomberg reported that